The prevalence of MS in the United States
Neurology2019Vol. 92(10), pp. e1029–e1040
Citations Over TimeTop 1% of 2019 papers
Mitchell T. Wallin, William J. Culpepper, Jonathan D. Campbell, Lorene M. Nelson, Annette Langer‐Gould, Ruth Ann Marrie, Gary Cutter, Wendy Kaye, Laurie Wagner, Helen Tremlett, Stephen L. Buka, Piyameth Dilokthornsakul, Barbara Topol, Lie H. Chen, Nicholas G. LaRocca
Abstract
The estimated US national MS prevalence for 2010 is the highest reported to date and provides evidence that the north-south gradient persists. Our rigorous algorithm-based approach to estimating prevalence is efficient and has the potential to be used for other chronic neurologic conditions.
Related Papers
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)